Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02053168 · ClinicalTrials.gov registry record · NA
A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02053168 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 33 participants.
The verdict
NCT02053168, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Collect data on safety, performance, and effectiveness of Phasix Mesh in subject requiring primary ventral and incisional hernias.
Interventions
- DEVICE Resorbable Mesh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02053168
The ClinicalTrials.gov registry entry for NCT02053168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resorbable Mesh is the first listed.
NCT02053168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02053168 about?
NCT02053168 is a clinical study titled "A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair". Collect data on safety, performance, and effectiveness of Phasix Mesh in subject requiring primary ventral and incisional hernias.
What is the current status of trial NCT02053168?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2014-02. Estimated completion is 2017-02-23.
What interventions are being tested in trial NCT02053168?
The interventions under investigation include: Resorbable Mesh (DEVICE).
Who is sponsoring clinical trial NCT02053168?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.